Three in four multinational corporations (MNCs) operating in mainland China have maintained or increased their investments in 2025, according to…
Read More »multinational corporations
China’s growing pipeline of novel drug candidates is expected to draw increased attention from global pharmaceutical companies and investors scouting…
Read More »As we approach 2025, China stands on the brink of a series of transformations. Geopolitical volatility and rising tariffs are…
Read More »Equinix plans to spend US$124 million to build its sixth data centre in Hong Kong, expanding its storage capacity to…
Read More »


